Deerfield Management Company, L.P. (Series C) Revolution Medicines, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$3.95 Billion
Q1 2025

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,317,332 shares of RVMD stock, worth $126 Million. This represents 2.97% of its overall portfolio holdings.

Number of Shares

3,317,332

Previous 3,258,332 1.81%

Holding current value

$126 Million

Previous $143 Million 17.7%

% of portfolio

2.97%

Previous 3.53%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$35.36 - $44.42 $2.09 Million - $2.62 Million	59,000 Added 1.81%	3,317,332 $117 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $14.9 Million - $20.9 Million	345,640 Added 11.87%	3,258,332 $143 Million
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $6.55 Million - $8.5 Million	-177,381 Reduced 5.74%	2,912,692 $132 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $24.6 Million - $45.7 Million	1,338,577 Added 76.42%	3,090,073 $88.6 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $18.7 Million - $24.9 Million	921,759 Added 111.09%	1,751,496 $46.9 Million
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $1.28 Million - $1.86 Million	-61,850 Reduced 6.94%	829,737 $18 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $35.4 Million - $51.1 Million	-2,000,000 Reduced 69.17%	891,587 $21.2 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $34.9 Million - $52 Million	2,000,000 Added 224.32%	2,891,587 $57 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $16.4 Million - $22.7 Million	-674,125 Reduced 43.06%	891,587 $22.4 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $3.74 Million - $6.12 Million	129,000 Added 8.98%	1,565,712 $49.7 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $1.5 Million - $2.2 Million	40,329 Added 2.89%	1,436,712 $65.9 Million
Q4 2020 Feb 16, 2021	SELL	$30.19 - $45.49 $12.1 Million - $18.2 Million	-400,000 Reduced 22.27%	1,396,383 $55.3 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $35.9 Million - $61.2 Million	1,796,383 New	1,796,383 $39.4 Million

Others Institutions Holding RVMD

# of Institutions

303

Shares Held

189M

Call Options Held

186K

Put Options Held

672K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.32B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account

Deerfield Management Company, L.P. (Series C) Revolution Medicines, Inc. Transaction History